Otto Shill, DO, FACP, DABOM

ShillMed operates as a medical weight loss and hormone replacement clinic in Spokane Valley, Washington, under the direction of Otto Shill, DO, FACP, DABOM. Dr. Shill holds dual board certifications in Internal Medicine and Obesity Medicine, positioning the practice to address metabolic health through evidence-based interventions. The clinic focuses on patients in the Spokane Valley area who require structured weight management programs and hormone optimization protocols delivered through in-person consultations.

The clinic's weight loss protocols center on FDA-approved GLP-1 receptor agonists including semaglutide, tirzepatide, and liraglutide. These peptide therapies work by regulating appetite, slowing gastric emptying, and improving glycemic control in patients with obesity or metabolic dysfunction. ShillMed integrates these pharmacologic interventions with personalized nutrition planning tailored to individual metabolic profiles, food preferences, and comorbid conditions. Dr. Shill's obesity medicine certification informs the selection and dosing of these peptides based on patient-specific factors including BMI, diabetes status, cardiovascular risk, and previous weight loss attempts. The practice does not offer telehealth services, requiring all patients to attend appointments at the Spokane Valley location for medication initiation, dose adjustments, and ongoing monitoring.

Dr. Shill's Fellowship in the American College of Physicians (FACP) and Diplomate status with the American Board of Obesity Medicine (DABOM) reflect advanced training in managing complex metabolic and endocrine conditions. His internal medicine background allows the clinic to address weight-related comorbidities such as hypertension, dyslipidemia, insulin resistance, and fatty liver disease within the same treatment framework. Hormone management services at ShillMed address imbalances that may contribute to weight gain, fatigue, or metabolic slowdown, though the clinic's primary emphasis remains on obesity medicine and nutritional intervention. The dual focus allows patients in Spokane Valley to receive coordinated care for interconnected metabolic and hormonal issues without requiring referrals to multiple specialists.

Patients beginning treatment at ShillMed undergo comprehensive metabolic assessments including body composition analysis, laboratory evaluation of thyroid function and sex hormones, and review of prior weight loss efforts. Dr. Shill uses this baseline data to construct individualized treatment plans that may combine peptide therapy with dietary modification, exercise prescription, and behavioral strategies. Follow-up visits track weight trends, medication tolerance, and metabolic markers to adjust peptide dosing or pivot treatment approaches as needed. The in-person consultation model enables direct physical examination, real-time problem-solving for side effects, and immediate access to Dr. Shill's clinical judgment during the weight loss process.

ShillMed's location in Spokane Valley serves patients throughout the greater Spokane metropolitan area seeking medical supervision for weight loss rather than commercial diet programs. The clinic's focus on FDA-approved peptide therapies distinguishes it from practices offering unregulated weight loss supplements or non-evidence-based interventions. Dr. Shill's obesity medicine board certification ensures treatment protocols align with current clinical guidelines for pharmacotherapy in obesity management. Patients requiring long-term weight maintenance, management of weight regain, or treatment of obesity-related complications benefit from the clinic's internal medicine foundation and specialized focus on metabolic health.